Prior to joining PROTEINA, Dr. Kim was a founding member and Managing Director at Geninus Inc. from 2019 to 2022, where she played a crucial role in the company’s successful IPO on KOSDAQ in 2021. Before that, she led the development of a cutting-edge cancer genome analysis solution at Samsung Medical Center, Samsung Genome Institute, gaining key insights into bringing innovative technologies to market. Leveraging her extensive experience in both product development and business leadership, Dr. Kim contributes to PROTEINA's growth, focusing on strategic partnerships, market expansion, and the development of business initiatives.